vimarsana.com

ஓஹியோ அடிப்படையிலானது ஆலிவ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Olive passes $4B valuation with new funding round

MedCity News Olive passes $4B valuation with new funding round Olive, which automates redundant tasks in healthcare, recently raised $400 million in a funding round. Since the start of the pandemic, the company has raised a total of $832 million.  Shares0 Olive, a startup developing software to automate administrative tasks for hospitals, recently doubled its valuation after raising a recent funding round. The Cleveland-based company recently passed a $4 billion valuation after raising $400 million in funding. Cleveland, Ohio-based Olive was founded in 2012. The company touts its identically named AI assistant, which is tasked with handling repetitive tasks, such as managing prior authorizations or inventory. More recently, it has added features to pull up patients’ insurance and contact information as they register for appointments. 

Health-Tech Firm Olive Valued at $4 Billion After Vista Round

We re #28! TSX rides commodity rally to outpace Dow Industrials Colin Stewart s Top Picks: June 30, 2021 U.S. stock euphoria abates at end of big first half Bruce Campbell s Top Picks: June 29, 2021 Lorne Steinberg s Top Picks: June 28, 2021 Wall Street and C-Suite grapple with a meme-stock new normal Haters everywhere in stock market after S&P 500 s big first half Larry Berman: Warning, the making of the Mother of all crashes Ryan Bushell s Top Picks: June 25, 2021 Banks easily clear U.S. stress tests, setting stage for payouts Pattie Lovett-Reid: Investors need to get realistic about return expectations Stan Wong s Top Picks: June 24, 2021 BofA favours Canada stocks with big discount to frothy S&P 500

Howard Hughes locks in new leases with five companies in Downtown Columbia

Howard Hughes locks in new leases with five companies in Downtown Columbia
bizjournals.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizjournals.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.